Weekly

It appears as though the potential risk of having taken the experimental COVID 19 vaccine are still being discovered 5 years after COVID changed the world as we know it. A recent Yale study has sparked controversy by suggesting a potential link between COVID-19 vaccines and a condition termed “post-vaccination syndrome” (PVS).

Millions of Americans have been hit with an unrelenting bug. Some say they feel worse than they felt during the pandemic. Is the virus getting stronger and adapting,? Yes. Is flu rising? Yes. Fatigue, fever, and cold sweats a common symptoms of RSV, Flu, and COVID. Based on symptoms alone, it is very difficult to tell whether you are experiencing one or the other and that is another tool the CDC and NIH are using to confuse the numbers and shuttle the blame.

Recent studies suggest that Paxlovid, an antiviral medication used to treat COVID-19, may not significantly benefit vaccinated seniors. Research conducted in Ontario, Canada, found that among vaccinated older adults, Paxlovid did not show a statistically significant reduction in COVID-19 hospitalizations or mortality rates. This contrasts with earlier studies that demonstrated the drug’s effectiveness in unvaccinated populations.